| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.52▲ | 2.53▼ | 2.53▼ | 2.43▲ | 2.33▲ |
| MA10 | 2.52▼ | 2.47▲ | 2.45▲ | 2.33▲ | 2.39▲ |
| MA20 | 2.43▲ | 2.36▲ | 2.35▲ | 2.31▲ | 2.39▲ |
| MA50 | 2.36▲ | 2.35▲ | 2.35▲ | 2.34▲ | 2.56▼ |
| MA100 | 2.38▲ | 2.39▲ | 2.38▲ | 2.40▲ | 4.64▼ |
| MA200 | 2.37▲ | 2.32▲ | 2.29▲ | 2.45▲ | 51.22▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.024▲ | 0.027▲ | 0.031▲ | 0.033▲ |
| RSI | 58.360▲ | 60.841▲ | 60.812▲ | 60.111▲ | 50.335▲ |
| STOCH | 33.677 | 67.761 | 68.940 | 63.267 | 33.427 |
| WILL %R | -42.105 | -35.556 | -35.556 | -32.727 | -54.054 |
| CCI | 32.234 | 66.677 | 70.382 | 157.635▲ | 108.057▲ |
|
Monday, April 28, 2025 01:00 PM
SAN FRANCISCO, CALIFORNIA, March 04, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ...
|
|
Thursday, April 24, 2025 01:00 PM
SAN FRANCISCO, CALIFORNIA, March 04, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ...
|
|
Tuesday, April 15, 2025 05:00 PM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 2.52 | 2.52 | 2.52 | 2.52 | 0 |
| 01/05/25 | 2.40 | 2.5849 | 2.34 | 2.45 | 9,337 |
| 30/04/25 | 2.34 | 2.70 | 2.34 | 2.42 | 23,392 |
| 29/04/25 | 2.36 | 2.495 | 2.30 | 2.45 | 174,193 |
| 28/04/25 | 2.32 | 2.33 | 2.28 | 2.30 | 8,764 |
| 25/04/25 | 2.30 | 2.32 | 2.28 | 2.28 | 10,903 |
| 24/04/25 | 2.31 | 2.33 | 2.24 | 2.2819 | 4,581 |
| 23/04/25 | 2.22 | 2.38 | 2.22 | 2.23 | 18,822 |
| 22/04/25 | 2.24 | 2.35 | 2.15 | 2.16 | 11,364 |
| 21/04/25 | 2.20 | 2.2499 | 2.16 | 2.17 | 4,963 |
|
|
||||
|
|
||||
|
|